nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Hydroxyurea—head and neck cancer	0.0773	0.49	CbGbCtD
Bepridil—ABCB1—Vinblastine—head and neck cancer	0.029	0.184	CbGbCtD
Bepridil—CYP2D6—Vinblastine—head and neck cancer	0.0274	0.174	CbGbCtD
Bepridil—KCNQ1—cochlea—head and neck cancer	0.0261	0.0774	CbGeAlD
Bepridil—KCNQ1—internal ear—head and neck cancer	0.0247	0.0734	CbGeAlD
Bepridil—ABCB1—Docetaxel—head and neck cancer	0.0239	0.152	CbGbCtD
Bepridil—CALM1—superior cervical ganglion—head and neck cancer	0.0213	0.0632	CbGeAlD
Bepridil—CACNA1D—cochlea—head and neck cancer	0.0181	0.0537	CbGeAlD
Bepridil—CACNA1D—internal ear—head and neck cancer	0.0171	0.0509	CbGeAlD
Bepridil—Distress—Hydroxyurea—head and neck cancer	0.0168	0.0838	CcSEcCtD
Bepridil—KCNQ1—ear—head and neck cancer	0.0167	0.0495	CbGeAlD
Bepridil—Superinfection—Fluorouracil—head and neck cancer	0.0148	0.0738	CcSEcCtD
Bepridil—CALM1—trigeminal nerve—head and neck cancer	0.012	0.0357	CbGeAlD
Bepridil—CACNA1D—ear—head and neck cancer	0.0115	0.0343	CbGeAlD
Bepridil—Emotional distress—Hydroxyurea—head and neck cancer	0.011	0.0547	CcSEcCtD
Bepridil—CALM1—cranial nerve—head and neck cancer	0.00857	0.0255	CbGeAlD
Bepridil—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00792	0.0396	CcSEcCtD
Bepridil—Emotional distress—Fluorouracil—head and neck cancer	0.00788	0.0394	CcSEcCtD
Bepridil—Skin irritation—Fluorouracil—head and neck cancer	0.00775	0.0387	CcSEcCtD
Bepridil—CALM2—ear—head and neck cancer	0.00701	0.0208	CbGeAlD
Bepridil—CALM1—ear—head and neck cancer	0.00698	0.0207	CbGeAlD
Bepridil—Sudden death—Fluorouracil—head and neck cancer	0.00655	0.0327	CcSEcCtD
Bepridil—CACNA2D2—neck—head and neck cancer	0.0061	0.0181	CbGeAlD
Bepridil—Sinus tachycardia—Docetaxel—head and neck cancer	0.00601	0.03	CcSEcCtD
Bepridil—KCNQ1—neck—head and neck cancer	0.00589	0.0175	CbGeAlD
Bepridil—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0057	0.0285	CcSEcCtD
Bepridil—TNNC1—connective tissue—head and neck cancer	0.00519	0.0154	CbGeAlD
Bepridil—KCNQ1—saliva-secreting gland—head and neck cancer	0.00459	0.0136	CbGeAlD
Bepridil—ATP1A1—exocrine gland—head and neck cancer	0.0044	0.0131	CbGeAlD
Bepridil—ATP1A1—hair follicle—head and neck cancer	0.0042	0.0125	CbGeAlD
Bepridil—CALM2—exocrine gland—head and neck cancer	0.00388	0.0115	CbGeAlD
Bepridil—CALM1—exocrine gland—head and neck cancer	0.00386	0.0115	CbGeAlD
Bepridil—CALM2—hair follicle—head and neck cancer	0.00369	0.011	CbGeAlD
Bepridil—CACNA1A—head—head and neck cancer	0.00366	0.0109	CbGeAlD
Bepridil—PDE1B—thyroid gland—head and neck cancer	0.0036	0.0107	CbGeAlD
Bepridil—TNNC1—thyroid gland—head and neck cancer	0.00345	0.0102	CbGeAlD
Bepridil—ATP1A1—mouth—head and neck cancer	0.00329	0.00978	CbGeAlD
Bepridil—PDE1B—head—head and neck cancer	0.00319	0.00948	CbGeAlD
Bepridil—Angina pectoris—Vinblastine—head and neck cancer	0.00312	0.0156	CcSEcCtD
Bepridil—PDE1A—thyroid gland—head and neck cancer	0.00302	0.00896	CbGeAlD
Bepridil—CACNA2D2—thyroid gland—head and neck cancer	0.0029	0.00862	CbGeAlD
Bepridil—CALM2—mouth—head and neck cancer	0.0029	0.00861	CbGeAlD
Bepridil—CALM1—mouth—head and neck cancer	0.00289	0.00857	CbGeAlD
Bepridil—Depression—Vinblastine—head and neck cancer	0.00285	0.0142	CcSEcCtD
Bepridil—ATP1A1—neck—head and neck cancer	0.00281	0.00836	CbGeAlD
Bepridil—KCNQ1—thyroid gland—head and neck cancer	0.0028	0.00833	CbGeAlD
Bepridil—CACNA1C—connective tissue—head and neck cancer	0.0027	0.00802	CbGeAlD
Bepridil—PDE1A—head—head and neck cancer	0.00268	0.00795	CbGeAlD
Bepridil—Drowsiness—Hydroxyurea—head and neck cancer	0.00261	0.013	CcSEcCtD
Bepridil—CACNA2D2—head—head and neck cancer	0.00258	0.00765	CbGeAlD
Bepridil—CALM3—parotid gland—head and neck cancer	0.00257	0.00764	CbGeAlD
Bepridil—Pharyngitis—Vinblastine—head and neck cancer	0.00255	0.0127	CcSEcCtD
Bepridil—Cardiac failure—Fluorouracil—head and neck cancer	0.00249	0.0125	CcSEcCtD
Bepridil—KCNQ1—head—head and neck cancer	0.00249	0.00739	CbGeAlD
Bepridil—CALM2—neck—head and neck cancer	0.00248	0.00736	CbGeAlD
Bepridil—CALM1—neck—head and neck cancer	0.00247	0.00733	CbGeAlD
Bepridil—CALM3—saliva-secreting gland—head and neck cancer	0.00246	0.00731	CbGeAlD
Bepridil—CACNA1H—thyroid gland—head and neck cancer	0.00235	0.00699	CbGeAlD
Bepridil—ATP1A1—parotid gland—head and neck cancer	0.00229	0.00681	CbGeAlD
Bepridil—PDE1B—lymph node—head and neck cancer	0.00224	0.00664	CbGeAlD
Bepridil—ATP1A1—saliva-secreting gland—head and neck cancer	0.0022	0.00652	CbGeAlD
Bepridil—TNNC1—lymph node—head and neck cancer	0.00214	0.00637	CbGeAlD
Bepridil—Angina pectoris—Fluorouracil—head and neck cancer	0.00205	0.0102	CcSEcCtD
Bepridil—CALM2—parotid gland—head and neck cancer	0.00202	0.006	CbGeAlD
Bepridil—ATP1A1—connective tissue—head and neck cancer	0.00202	0.00599	CbGeAlD
Bepridil—Vertigo—Vinblastine—head and neck cancer	0.00201	0.01	CcSEcCtD
Bepridil—CACNA1D—thyroid gland—head and neck cancer	0.00194	0.00577	CbGeAlD
Bepridil—CALM2—saliva-secreting gland—head and neck cancer	0.00193	0.00574	CbGeAlD
Bepridil—Hypertension—Vinblastine—head and neck cancer	0.00193	0.00963	CcSEcCtD
Bepridil—CALM1—saliva-secreting gland—head and neck cancer	0.00192	0.00572	CbGeAlD
Bepridil—ATP1A1—epithelium—head and neck cancer	0.00192	0.00569	CbGeAlD
Bepridil—CALM3—trachea—head and neck cancer	0.0019	0.00564	CbGeAlD
Bepridil—PDE1A—lymph node—head and neck cancer	0.00187	0.00556	CbGeAlD
Bepridil—CACNA2D2—lymph node—head and neck cancer	0.0018	0.00536	CbGeAlD
Bepridil—Cardiac failure—Docetaxel—head and neck cancer	0.0018	0.00899	CcSEcCtD
Bepridil—CALM2—connective tissue—head and neck cancer	0.00178	0.00528	CbGeAlD
Bepridil—CALM1—connective tissue—head and neck cancer	0.00177	0.00525	CbGeAlD
Bepridil—KCNQ1—lymph node—head and neck cancer	0.00174	0.00517	CbGeAlD
Bepridil—Anorexia—Vinblastine—head and neck cancer	0.00174	0.00868	CcSEcCtD
Bepridil—CACNA1D—head—head and neck cancer	0.00172	0.00512	CbGeAlD
Bepridil—ATP1A1—trachea—head and neck cancer	0.00169	0.00503	CbGeAlD
Bepridil—Rhinitis—Fluorouracil—head and neck cancer	0.00169	0.00843	CcSEcCtD
Bepridil—CALM2—epithelium—head and neck cancer	0.00169	0.00501	CbGeAlD
Bepridil—CALM1—epithelium—head and neck cancer	0.00168	0.00499	CbGeAlD
Bepridil—Pharyngitis—Fluorouracil—head and neck cancer	0.00167	0.00835	CcSEcCtD
Bepridil—Oedema—Hydroxyurea—head and neck cancer	0.00166	0.0083	CcSEcCtD
Bepridil—Paraesthesia—Vinblastine—head and neck cancer	0.00164	0.00817	CcSEcCtD
Bepridil—Liver function test abnormal—Docetaxel—head and neck cancer	0.00162	0.0081	CcSEcCtD
Bepridil—CACNA1C—head—head and neck cancer	0.00159	0.00473	CbGeAlD
Bepridil—Anorexia—Hydroxyurea—head and neck cancer	0.00158	0.00791	CcSEcCtD
Bepridil—Decreased appetite—Vinblastine—head and neck cancer	0.00158	0.00791	CcSEcCtD
Bepridil—Pain—Vinblastine—head and neck cancer	0.00156	0.00779	CcSEcCtD
Bepridil—Constipation—Vinblastine—head and neck cancer	0.00156	0.00779	CcSEcCtD
Bepridil—Arrhythmia—Fluorouracil—head and neck cancer	0.0015	0.00751	CcSEcCtD
Bepridil—CALM3—thyroid gland—head and neck cancer	0.0015	0.00446	CbGeAlD
Bepridil—CALM2—trachea—head and neck cancer	0.00149	0.00443	CbGeAlD
Bepridil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00149	0.00744	CcSEcCtD
Bepridil—CALM1—trachea—head and neck cancer	0.00148	0.00441	CbGeAlD
Bepridil—Dyspnoea—Hydroxyurea—head and neck cancer	0.00148	0.0074	CcSEcCtD
Bepridil—Angina pectoris—Docetaxel—head and neck cancer	0.00148	0.00739	CcSEcCtD
Bepridil—Somnolence—Hydroxyurea—head and neck cancer	0.00148	0.00738	CcSEcCtD
Bepridil—ATP1A1—lymphoid tissue—head and neck cancer	0.00148	0.00438	CbGeAlD
Bepridil—Dyspepsia—Hydroxyurea—head and neck cancer	0.00146	0.00731	CcSEcCtD
Bepridil—CACNA1H—lymph node—head and neck cancer	0.00146	0.00434	CbGeAlD
Bepridil—Decreased appetite—Hydroxyurea—head and neck cancer	0.00144	0.00722	CcSEcCtD
Bepridil—Abdominal pain—Vinblastine—head and neck cancer	0.00144	0.0072	CcSEcCtD
Bepridil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00143	0.00717	CcSEcCtD
Bepridil—Constipation—Hydroxyurea—head and neck cancer	0.00142	0.0071	CcSEcCtD
Bepridil—Pain—Hydroxyurea—head and neck cancer	0.00142	0.0071	CcSEcCtD
Bepridil—Vision blurred—Fluorouracil—head and neck cancer	0.00138	0.0069	CcSEcCtD
Bepridil—ATP1A1—thyroid gland—head and neck cancer	0.00134	0.00398	CbGeAlD
Bepridil—Body temperature increased—Hydroxyurea—head and neck cancer	0.00131	0.00656	CcSEcCtD
Bepridil—Asthenia—Vinblastine—head and neck cancer	0.00131	0.00653	CcSEcCtD
Bepridil—CALM2—lymphoid tissue—head and neck cancer	0.0013	0.00386	CbGeAlD
Bepridil—CALM1—lymphoid tissue—head and neck cancer	0.00129	0.00384	CbGeAlD
Bepridil—Myalgia—Fluorouracil—head and neck cancer	0.00125	0.00623	CcSEcCtD
Bepridil—Diarrhoea—Vinblastine—head and neck cancer	0.00125	0.00623	CcSEcCtD
Bepridil—Rhinitis—Docetaxel—head and neck cancer	0.00122	0.00609	CcSEcCtD
Bepridil—CACNA1D—lymph node—head and neck cancer	0.00121	0.00359	CbGeAlD
Bepridil—Pharyngitis—Docetaxel—head and neck cancer	0.00121	0.00603	CcSEcCtD
Bepridil—Dizziness—Vinblastine—head and neck cancer	0.0012	0.00602	CcSEcCtD
Bepridil—Oedema—Fluorouracil—head and neck cancer	0.0012	0.00598	CcSEcCtD
Bepridil—Asthenia—Hydroxyurea—head and neck cancer	0.00119	0.00596	CcSEcCtD
Bepridil—ATP1A1—head—head and neck cancer	0.00119	0.00353	CbGeAlD
Bepridil—CALM2—thyroid gland—head and neck cancer	0.00118	0.0035	CbGeAlD
Bepridil—CALM1—thyroid gland—head and neck cancer	0.00117	0.00349	CbGeAlD
Bepridil—Headache—Vinblastine—head and neck cancer	0.00114	0.0057	CcSEcCtD
Bepridil—Anorexia—Fluorouracil—head and neck cancer	0.00114	0.0057	CcSEcCtD
Bepridil—Diarrhoea—Hydroxyurea—head and neck cancer	0.00114	0.00568	CcSEcCtD
Bepridil—Cardiac disorder—Docetaxel—head and neck cancer	0.00113	0.00563	CcSEcCtD
Bepridil—CACNA1C—lymph node—head and neck cancer	0.00111	0.00331	CbGeAlD
Bepridil—Dizziness—Hydroxyurea—head and neck cancer	0.0011	0.00549	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00109	0.00544	CcSEcCtD
Bepridil—Arrhythmia—Docetaxel—head and neck cancer	0.00109	0.00542	CcSEcCtD
Bepridil—Nausea—Vinblastine—head and neck cancer	0.00108	0.00541	CcSEcCtD
Bepridil—Insomnia—Fluorouracil—head and neck cancer	0.00108	0.00541	CcSEcCtD
Bepridil—Paraesthesia—Fluorouracil—head and neck cancer	0.00107	0.00537	CcSEcCtD
Bepridil—Dyspnoea—Fluorouracil—head and neck cancer	0.00107	0.00533	CcSEcCtD
Bepridil—Somnolence—Fluorouracil—head and neck cancer	0.00106	0.00531	CcSEcCtD
Bepridil—Dyspepsia—Fluorouracil—head and neck cancer	0.00105	0.00526	CcSEcCtD
Bepridil—Rash—Hydroxyurea—head and neck cancer	0.00105	0.00523	CcSEcCtD
Bepridil—CALM2—head—head and neck cancer	0.00105	0.00311	CbGeAlD
Bepridil—Dermatitis—Hydroxyurea—head and neck cancer	0.00105	0.00523	CcSEcCtD
Bepridil—CALM1—head—head and neck cancer	0.00104	0.00309	CbGeAlD
Bepridil—Headache—Hydroxyurea—head and neck cancer	0.00104	0.0052	CcSEcCtD
Bepridil—Decreased appetite—Fluorouracil—head and neck cancer	0.00104	0.00519	CcSEcCtD
Bepridil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00103	0.00516	CcSEcCtD
Bepridil—Pain—Fluorouracil—head and neck cancer	0.00102	0.00511	CcSEcCtD
Bepridil—Nausea—Hydroxyurea—head and neck cancer	0.000987	0.00493	CcSEcCtD
Bepridil—Syncope—Docetaxel—head and neck cancer	0.000948	0.00474	CcSEcCtD
Bepridil—KCNH2—head—head and neck cancer	0.000948	0.00282	CbGeAlD
Bepridil—Body temperature increased—Fluorouracil—head and neck cancer	0.000945	0.00472	CcSEcCtD
Bepridil—Palpitations—Docetaxel—head and neck cancer	0.000935	0.00467	CcSEcCtD
Bepridil—CALM3—lymph node—head and neck cancer	0.000933	0.00277	CbGeAlD
Bepridil—Loss of consciousness—Docetaxel—head and neck cancer	0.00093	0.00465	CcSEcCtD
Bepridil—Cough—Docetaxel—head and neck cancer	0.000923	0.00461	CcSEcCtD
Bepridil—Hypertension—Docetaxel—head and neck cancer	0.000913	0.00456	CcSEcCtD
Bepridil—Myalgia—Docetaxel—head and neck cancer	0.0009	0.0045	CcSEcCtD
Bepridil—Dry mouth—Docetaxel—head and neck cancer	0.000881	0.0044	CcSEcCtD
Bepridil—Oedema—Docetaxel—head and neck cancer	0.000863	0.00431	CcSEcCtD
Bepridil—Shock—Docetaxel—head and neck cancer	0.000849	0.00424	CcSEcCtD
Bepridil—ATP1A1—lymph node—head and neck cancer	0.000832	0.00247	CbGeAlD
Bepridil—Anorexia—Docetaxel—head and neck cancer	0.000823	0.00411	CcSEcCtD
Bepridil—Diarrhoea—Fluorouracil—head and neck cancer	0.000818	0.00409	CcSEcCtD
Bepridil—Dizziness—Fluorouracil—head and neck cancer	0.000791	0.00395	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000786	0.00393	CcSEcCtD
Bepridil—Insomnia—Docetaxel—head and neck cancer	0.000781	0.0039	CcSEcCtD
Bepridil—Paraesthesia—Docetaxel—head and neck cancer	0.000775	0.00387	CcSEcCtD
Bepridil—Dyspnoea—Docetaxel—head and neck cancer	0.00077	0.00385	CcSEcCtD
Bepridil—Somnolence—Docetaxel—head and neck cancer	0.000767	0.00383	CcSEcCtD
Bepridil—Dyspepsia—Docetaxel—head and neck cancer	0.00076	0.0038	CcSEcCtD
Bepridil—Rash—Fluorouracil—head and neck cancer	0.000754	0.00377	CcSEcCtD
Bepridil—Dermatitis—Fluorouracil—head and neck cancer	0.000753	0.00376	CcSEcCtD
Bepridil—Decreased appetite—Docetaxel—head and neck cancer	0.00075	0.00375	CcSEcCtD
Bepridil—Headache—Fluorouracil—head and neck cancer	0.000749	0.00374	CcSEcCtD
Bepridil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000745	0.00372	CcSEcCtD
Bepridil—Constipation—Docetaxel—head and neck cancer	0.000738	0.00369	CcSEcCtD
Bepridil—Pain—Docetaxel—head and neck cancer	0.000738	0.00369	CcSEcCtD
Bepridil—CALM2—lymph node—head and neck cancer	0.000733	0.00218	CbGeAlD
Bepridil—CALM1—lymph node—head and neck cancer	0.00073	0.00217	CbGeAlD
Bepridil—Nausea—Fluorouracil—head and neck cancer	0.00071	0.00355	CcSEcCtD
Bepridil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000706	0.00353	CcSEcCtD
Bepridil—Abdominal pain—Docetaxel—head and neck cancer	0.000682	0.00341	CcSEcCtD
Bepridil—Body temperature increased—Docetaxel—head and neck cancer	0.000682	0.00341	CcSEcCtD
Bepridil—ABCB1—epithelium—head and neck cancer	0.00067	0.00199	CbGeAlD
Bepridil—KCNH2—lymph node—head and neck cancer	0.000664	0.00197	CbGeAlD
Bepridil—Asthenia—Docetaxel—head and neck cancer	0.000619	0.00309	CcSEcCtD
Bepridil—ABCB1—trachea—head and neck cancer	0.000593	0.00176	CbGeAlD
Bepridil—Diarrhoea—Docetaxel—head and neck cancer	0.000591	0.00295	CcSEcCtD
Bepridil—CYP2D6—head—head and neck cancer	0.000578	0.00172	CbGeAlD
Bepridil—Dizziness—Docetaxel—head and neck cancer	0.000571	0.00285	CcSEcCtD
Bepridil—Rash—Docetaxel—head and neck cancer	0.000544	0.00272	CcSEcCtD
Bepridil—Dermatitis—Docetaxel—head and neck cancer	0.000544	0.00272	CcSEcCtD
Bepridil—Headache—Docetaxel—head and neck cancer	0.000541	0.0027	CcSEcCtD
Bepridil—ABCB1—lymphoid tissue—head and neck cancer	0.000516	0.00153	CbGeAlD
Bepridil—Nausea—Docetaxel—head and neck cancer	0.000513	0.00256	CcSEcCtD
Bepridil—ABCB1—thyroid gland—head and neck cancer	0.000469	0.00139	CbGeAlD
Bepridil—ABCB1—head—head and neck cancer	0.000416	0.00124	CbGeAlD
Bepridil—ABCB1—lymph node—head and neck cancer	0.000291	0.000865	CbGeAlD
Bepridil—PDE1B—Immune System—HRAS—head and neck cancer	4.77e-05	0.000156	CbGpPWpGaD
Bepridil—PDE1B—Disease—PIK3CA—head and neck cancer	4.76e-05	0.000156	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PTEN—head and neck cancer	4.72e-05	0.000154	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—MAPK3—head and neck cancer	4.72e-05	0.000154	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—VEGFA—head and neck cancer	4.66e-05	0.000153	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—AKT1—head and neck cancer	4.62e-05	0.000151	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—PTEN—head and neck cancer	4.62e-05	0.000151	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—PTEN—head and neck cancer	4.62e-05	0.000151	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—STAT3—head and neck cancer	4.62e-05	0.000151	CbGpPWpGaD
Bepridil—CALM3—Metabolism—TYMS—head and neck cancer	4.61e-05	0.000151	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—AKT1—head and neck cancer	4.6e-05	0.000151	CbGpPWpGaD
Bepridil—PDE1A—Immune System—AKT1—head and neck cancer	4.6e-05	0.000151	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—MAPK3—head and neck cancer	4.56e-05	0.000149	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—MAPK3—head and neck cancer	4.56e-05	0.000149	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTM1—head and neck cancer	4.55e-05	0.000149	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—MAPK1—head and neck cancer	4.49e-05	0.000147	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—AKT1—head and neck cancer	4.47e-05	0.000146	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—AKT1—head and neck cancer	4.47e-05	0.000146	CbGpPWpGaD
Bepridil—CALM1—Metabolism—TYMS—head and neck cancer	4.46e-05	0.000146	CbGpPWpGaD
Bepridil—CALM2—Metabolism—TYMS—head and neck cancer	4.46e-05	0.000146	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MAPK3—head and neck cancer	4.41e-05	0.000144	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTM1—head and neck cancer	4.4e-05	0.000144	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTM1—head and neck cancer	4.4e-05	0.000144	CbGpPWpGaD
Bepridil—PDE1B—Disease—HRAS—head and neck cancer	4.4e-05	0.000144	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GPX1—head and neck cancer	4.36e-05	0.000143	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—MAPK1—head and neck cancer	4.34e-05	0.000142	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—MAPK1—head and neck cancer	4.34e-05	0.000142	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP1A1—head and neck cancer	4.32e-05	0.000141	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—VEGFA—head and neck cancer	4.26e-05	0.00014	CbGpPWpGaD
Bepridil—PDE1A—Disease—AKT1—head and neck cancer	4.25e-05	0.000139	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—MAPK3—head and neck cancer	4.25e-05	0.000139	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—STAT3—head and neck cancer	4.22e-05	0.000138	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GPX1—head and neck cancer	4.22e-05	0.000138	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GPX1—head and neck cancer	4.22e-05	0.000138	CbGpPWpGaD
Bepridil—PDE1B—Immune System—AKT1—head and neck cancer	4.21e-05	0.000138	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MAPK1—head and neck cancer	4.2e-05	0.000137	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—head and neck cancer	4.2e-05	0.000137	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP1A1—head and neck cancer	4.17e-05	0.000137	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP1A1—head and neck cancer	4.17e-05	0.000137	CbGpPWpGaD
Bepridil—CALM3—Disease—NOTCH1—head and neck cancer	4.13e-05	0.000135	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—MAPK3—head and neck cancer	4.11e-05	0.000134	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—MAPK3—head and neck cancer	4.11e-05	0.000134	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—PIK3CA—head and neck cancer	4.08e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Immune System—CASP8—head and neck cancer	4.07e-05	0.000133	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—MAPK1—head and neck cancer	4.04e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—head and neck cancer	4.04e-05	0.000132	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MAPK3—head and neck cancer	4.03e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Immune System—CDH1—head and neck cancer	4.02e-05	0.000132	CbGpPWpGaD
Bepridil—CALM2—Disease—NOTCH1—head and neck cancer	3.99e-05	0.000131	CbGpPWpGaD
Bepridil—CALM1—Disease—NOTCH1—head and neck cancer	3.99e-05	0.000131	CbGpPWpGaD
Bepridil—CALM1—Immune System—CASP8—head and neck cancer	3.94e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Immune System—CASP8—head and neck cancer	3.94e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—MAPK1—head and neck cancer	3.91e-05	0.000128	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—MAPK1—head and neck cancer	3.91e-05	0.000128	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—head and neck cancer	3.91e-05	0.000128	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—head and neck cancer	3.91e-05	0.000128	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—PIK3CA—head and neck cancer	3.89e-05	0.000127	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDH1—head and neck cancer	3.89e-05	0.000127	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDH1—head and neck cancer	3.89e-05	0.000127	CbGpPWpGaD
Bepridil—PDE1B—Disease—AKT1—head and neck cancer	3.88e-05	0.000127	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—head and neck cancer	3.88e-05	0.000127	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MAPK1—head and neck cancer	3.84e-05	0.000126	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—head and neck cancer	3.84e-05	0.000126	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—head and neck cancer	3.77e-05	0.000123	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—PIK3CA—head and neck cancer	3.77e-05	0.000123	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—PIK3CA—head and neck cancer	3.77e-05	0.000123	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—head and neck cancer	3.75e-05	0.000123	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—head and neck cancer	3.75e-05	0.000123	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—head and neck cancer	3.64e-05	0.000119	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—head and neck cancer	3.64e-05	0.000119	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—PIK3CA—head and neck cancer	3.64e-05	0.000119	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—HRAS—head and neck cancer	3.6e-05	0.000118	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PIK3CA—head and neck cancer	3.58e-05	0.000117	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—head and neck cancer	3.52e-05	0.000115	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—PIK3CA—head and neck cancer	3.51e-05	0.000115	CbGpPWpGaD
Bepridil—CALM3—Immune System—BCL2—head and neck cancer	3.49e-05	0.000114	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TYMS—head and neck cancer	3.49e-05	0.000114	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—HRAS—head and neck cancer	3.49e-05	0.000114	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—HRAS—head and neck cancer	3.49e-05	0.000114	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTM1—head and neck cancer	3.45e-05	0.000113	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—PIK3CA—head and neck cancer	3.39e-05	0.000111	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—PIK3CA—head and neck cancer	3.39e-05	0.000111	CbGpPWpGaD
Bepridil—CALM2—Immune System—BCL2—head and neck cancer	3.38e-05	0.000111	CbGpPWpGaD
Bepridil—CALM1—Immune System—BCL2—head and neck cancer	3.38e-05	0.000111	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRAS—head and neck cancer	3.37e-05	0.00011	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL2—head and neck cancer	3.37e-05	0.00011	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—PIK3CA—head and neck cancer	3.37e-05	0.00011	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AKT1—head and neck cancer	3.33e-05	0.000109	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PIK3CA—head and neck cancer	3.33e-05	0.000109	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GPX1—head and neck cancer	3.3e-05	0.000108	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TYMS—head and neck cancer	3.29e-05	0.000108	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.27e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL2—head and neck cancer	3.26e-05	0.000107	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL2—head and neck cancer	3.26e-05	0.000107	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—PIK3CA—head and neck cancer	3.26e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—PIK3CA—head and neck cancer	3.26e-05	0.000107	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.25e-05	0.000106	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HRAS—head and neck cancer	3.24e-05	0.000106	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—head and neck cancer	3.22e-05	0.000105	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—AKT1—head and neck cancer	3.18e-05	0.000104	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HRAS—head and neck cancer	3.14e-05	0.000103	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HRAS—head and neck cancer	3.14e-05	0.000103	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HRAS—head and neck cancer	3.11e-05	0.000102	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GPX1—head and neck cancer	3.11e-05	0.000102	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.08e-05	0.000101	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRAS—head and neck cancer	3.08e-05	0.000101	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—AKT1—head and neck cancer	3.08e-05	0.000101	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—head and neck cancer	3.08e-05	0.000101	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL2—head and neck cancer	3.08e-05	0.000101	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—head and neck cancer	3.06e-05	0.0001	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—head and neck cancer	3.01e-05	9.86e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—head and neck cancer	3.01e-05	9.86e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL2—head and neck cancer	2.98e-05	9.74e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL2—head and neck cancer	2.98e-05	9.74e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—head and neck cancer	2.97e-05	9.73e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—head and neck cancer	2.96e-05	9.7e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—head and neck cancer	2.96e-05	9.7e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—head and neck cancer	2.93e-05	9.58e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PTEN—head and neck cancer	2.89e-05	9.47e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOTCH1—head and neck cancer	2.89e-05	9.46e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—head and neck cancer	2.86e-05	9.37e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PTEN—head and neck cancer	2.8e-05	9.16e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PTEN—head and neck cancer	2.8e-05	9.16e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOTCH1—head and neck cancer	2.8e-05	9.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOTCH1—head and neck cancer	2.8e-05	9.15e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—head and neck cancer	2.77e-05	9.07e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—head and neck cancer	2.77e-05	9.07e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—head and neck cancer	2.75e-05	9e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—head and neck cancer	2.72e-05	8.9e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK3—head and neck cancer	2.71e-05	8.86e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTEN—head and neck cancer	2.67e-05	8.75e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—head and neck cancer	2.66e-05	8.71e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—head and neck cancer	2.66e-05	8.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK3—head and neck cancer	2.62e-05	8.57e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK3—head and neck cancer	2.62e-05	8.57e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—head and neck cancer	2.59e-05	8.47e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTEN—head and neck cancer	2.59e-05	8.46e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTEN—head and neck cancer	2.59e-05	8.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK1—head and neck cancer	2.58e-05	8.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—head and neck cancer	2.58e-05	8.43e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—head and neck cancer	2.57e-05	8.4e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—head and neck cancer	2.5e-05	8.2e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—head and neck cancer	2.5e-05	8.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK1—head and neck cancer	2.49e-05	8.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK1—head and neck cancer	2.49e-05	8.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—head and neck cancer	2.49e-05	8.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—head and neck cancer	2.49e-05	8.15e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—head and neck cancer	2.48e-05	8.12e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—head and neck cancer	2.48e-05	8.12e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK3—head and neck cancer	2.47e-05	8.09e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK3—head and neck cancer	2.39e-05	7.83e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK3—head and neck cancer	2.39e-05	7.83e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—head and neck cancer	2.39e-05	7.82e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK1—head and neck cancer	2.35e-05	7.7e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—head and neck cancer	2.35e-05	7.7e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—head and neck cancer	2.31e-05	7.57e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—head and neck cancer	2.31e-05	7.57e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK3—head and neck cancer	2.28e-05	7.47e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK1—head and neck cancer	2.28e-05	7.45e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK1—head and neck cancer	2.28e-05	7.45e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—head and neck cancer	2.28e-05	7.45e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—head and neck cancer	2.28e-05	7.45e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTEN—head and neck cancer	2.24e-05	7.32e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—head and neck cancer	2.23e-05	7.31e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK3—head and neck cancer	2.21e-05	7.23e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK3—head and neck cancer	2.21e-05	7.23e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK1—head and neck cancer	2.17e-05	7.11e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—head and neck cancer	2.17e-05	7.11e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTEN—head and neck cancer	2.17e-05	7.09e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTEN—head and neck cancer	2.17e-05	7.09e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—head and neck cancer	2.16e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—head and neck cancer	2.16e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK1—head and neck cancer	2.1e-05	6.88e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK1—head and neck cancer	2.1e-05	6.88e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—head and neck cancer	2.1e-05	6.88e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—head and neck cancer	2.1e-05	6.88e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—head and neck cancer	2.07e-05	6.77e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—head and neck cancer	2.04e-05	6.68e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—head and neck cancer	2e-05	6.55e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—head and neck cancer	2e-05	6.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—head and neck cancer	1.99e-05	6.51e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—head and neck cancer	1.98e-05	6.46e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—head and neck cancer	1.98e-05	6.46e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—head and neck cancer	1.94e-05	6.37e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—head and neck cancer	1.94e-05	6.35e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—head and neck cancer	1.92e-05	6.3e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—head and neck cancer	1.92e-05	6.3e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—head and neck cancer	1.89e-05	6.18e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—head and neck cancer	1.89e-05	6.17e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—head and neck cancer	1.88e-05	6.14e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—head and neck cancer	1.88e-05	6.14e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTEN—head and neck cancer	1.87e-05	6.12e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.83e-05	6e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—head and neck cancer	1.83e-05	5.98e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—head and neck cancer	1.83e-05	5.98e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—head and neck cancer	1.83e-05	5.98e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—head and neck cancer	1.82e-05	5.97e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—head and neck cancer	1.82e-05	5.97e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTEN—head and neck cancer	1.81e-05	5.92e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTEN—head and neck cancer	1.81e-05	5.92e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—head and neck cancer	1.77e-05	5.78e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—head and neck cancer	1.77e-05	5.78e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—head and neck cancer	1.74e-05	5.71e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTEN—head and neck cancer	1.7e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—head and neck cancer	1.69e-05	5.53e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—head and neck cancer	1.69e-05	5.52e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—head and neck cancer	1.69e-05	5.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—head and neck cancer	1.67e-05	5.48e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—head and neck cancer	1.67e-05	5.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—head and neck cancer	1.64e-05	5.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—head and neck cancer	1.64e-05	5.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—head and neck cancer	1.62e-05	5.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—head and neck cancer	1.62e-05	5.3e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—head and neck cancer	1.61e-05	5.28e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—head and neck cancer	1.61e-05	5.28e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK3—head and neck cancer	1.6e-05	5.23e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTEN—head and neck cancer	1.6e-05	5.23e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—head and neck cancer	1.58e-05	5.17e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK3—head and neck cancer	1.55e-05	5.06e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK3—head and neck cancer	1.55e-05	5.06e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—head and neck cancer	1.54e-05	5.04e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—head and neck cancer	1.53e-05	5e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—head and neck cancer	1.53e-05	5e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK1—head and neck cancer	1.52e-05	4.98e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—head and neck cancer	1.52e-05	4.98e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—head and neck cancer	1.49e-05	4.88e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—head and neck cancer	1.49e-05	4.88e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK1—head and neck cancer	1.47e-05	4.82e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK1—head and neck cancer	1.47e-05	4.82e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—head and neck cancer	1.47e-05	4.82e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—head and neck cancer	1.47e-05	4.82e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—head and neck cancer	1.32e-05	4.32e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—head and neck cancer	1.29e-05	4.22e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—head and neck cancer	1.28e-05	4.18e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—head and neck cancer	1.28e-05	4.18e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—head and neck cancer	1.28e-05	4.18e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—head and neck cancer	1.25e-05	4.08e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—head and neck cancer	1.25e-05	4.08e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—head and neck cancer	1.24e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—head and neck cancer	1.24e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—head and neck cancer	1.22e-05	4e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.2e-05	3.92e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—head and neck cancer	1.18e-05	3.87e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—head and neck cancer	1.18e-05	3.87e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.13e-05	3.69e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	3.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—head and neck cancer	1.04e-05	3.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—head and neck cancer	1.04e-05	3.41e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—head and neck cancer	9.78e-06	3.2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—head and neck cancer	9.21e-06	3.01e-05	CbGpPWpGaD
